111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
51.07%
Revenue growth above 1.5x CX's 13.06%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
119.16%
Gross profit growth above 1.5x CX's 23.58%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-100.00%
Negative EBIT growth while CX is at 89.85%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
10650.00%
Operating income growth above 1.5x CX's 70.77%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
1503.19%
Positive net income growth while CX is negative. John Neff might see a big relative performance advantage.
1400.00%
Positive EPS growth while CX is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
1393.33%
Positive diluted EPS growth while CX is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.28%
Share reduction while CX is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.15%
Diluted share change of 0.15% while CX is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
318.04%
OCF growth at 75-90% of CX's 389.27%. Bill Ackman would demand better working capital management or cost discipline.
151.80%
FCF growth similar to CX's 141.07%. Walter Schloss would attribute it to parallel capital spending and operational models.
30.07%
10Y revenue/share CAGR above 1.5x CX's 9.37%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
92.82%
5Y revenue/share CAGR above 1.5x CX's 58.59%. David Dodd would look for consistent product or market expansions fueling outperformance.
-22.83%
Negative 3Y CAGR while CX stands at 1.13%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
1279.14%
Positive long-term OCF/share growth while CX is negative. John Neff would see a structural advantage in sustained cash generation.
241.68%
5Y OCF/share CAGR above 1.5x CX's 108.30%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
408.16%
Positive 3Y OCF/share CAGR while CX is negative. John Neff might see a big short-term edge in operational efficiency.
3324.04%
Net income/share CAGR above 1.5x CX's 184.58% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
655.30%
5Y net income/share CAGR at 50-75% of CX's 911.84%. Martin Whitman might see a shortfall in operational efficiency or brand power.
-28.57%
Negative 3Y CAGR while CX is 19.86%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
113.09%
10Y equity/share CAGR above 1.5x CX's 52.73%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
41.01%
5Y equity/share CAGR at 50-75% of CX's 69.54%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
21.85%
3Y equity/share CAGR at 50-75% of CX's 32.00%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
153.74%
Dividend/share CAGR of 153.74% while CX is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
20.57%
Dividend/share CAGR of 20.57% while CX is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-18.96%
Negative near-term dividend growth while CX invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
26.24%
AR growth well above CX's 6.39%. Michael Burry fears inflated revenue or higher default risk in the near future.
1.83%
Inventory shrinking or stable vs. CX's 4.08%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
3.97%
Asset growth 1.25-1.5x CX's 2.96%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
5.99%
BV/share growth above 1.5x CX's 2.22%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.96%
Debt growth of 0.96% while CX is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
15.66%
SG&A growth well above CX's 8.51%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.
